Stéphane Laurent: Key Highlights of ISBT 2026 for INLOG
Stéphane Laurent, International Sales Director at INLOG, Consultant -Advisor at ADEN Developpement-Consulting Healthcare, shared a post on LinkedIn:
“Key Highlights of International Society of Blood Transfusion (ISBT) 2026 Kuala Lumpur for INLOG
Strengthening INLOG’s international position as a leading provider of Blood Donor Management and Blood Establishment Information Systems (BBIS).
Showcasing the complete EdgeBlood, Blood Donor Online (BDO) and EdgeCell portfolio to the global transfusion medicine community.
Meeting national Blood Services, Ministries of Health, Red Cross organizations and major hospitals from across the world.
Accelerating expansion across ASEAN, with a particular focus on Malaysia, Indonesia, Thailand, Vietnam, Singapore and the Philippines.
Developing strategic distribution partnerships with leading regional healthcare technology companies.
Exploring long-term collaborations with IVD, automation and medical device manufacturers to deliver integrated solutions.
Promoting INLOG’s 20-year experience alongside the French Blood Establishment (EFS) as a benchmark for digital transformation in transfusion medicine.
Demonstrating end-to-end digital management covering donor recruitment, collection, testing, processing, inventory, distribution, traceability and haemovigilance.
Highlighting INLOG’s expertise beyond blood management with cells, tissues, organs, cord blood and human milk bank management through EdgeCell.
Presenting innovative digital donor engagement solutions, including online donor questionnaires, appointment scheduling and donor communication.
Discussing interoperability, cybersecurity, cloud architectures, AI opportunities and international standards with healthcare partners.
International Society of Blood Transfusion (ISBT) is not only where the transfusion community meets—it is where the future of Blood Donor
Management is designed together.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy